cost management Page 11

Keyword: cost management

196 results found
Which health benefits do employees really want?

Just 11 per cent of employees are completely satisfied with the coverage levels for all five of the major areas of their health benefits plan, according to the 2017 Sanofi Canada health-care survey. Members are especially keen to boost their coverage for major dental services (25 per cent), vision care (21 per cent) and paramedical […]

  • By: Staff
  • May 29, 2017 September 13, 2019
  • 09:05
WSIB drug changes shifted claims to other insurers: report

Ontario’s Workplace Safety and Insurance Board spent 33 per cent less on prescription drugs in 2015 than it did in 2010. The board has claimed the $34-million difference was due to lower drug prices and fewer claims entering the system. But a Toronto legal clinic is arguing the cost savings actually stem from reduced services to injured […]

  • By: Staff
  • May 24, 2017 September 13, 2019
  • 10:30
Feds aim to lower drug prices with budget allocations

In the 2017 budget released last week, the federal government said it’s aiming to lower pharmaceutical prices and improve access to prescription medications through significant investments in a variety of health-care agencies. The government has committed $140.3 million over five years, starting in 2017-2018, to Health Canada, the Patented Medicine Prices Review Board and the Canadian Agency for […]

What’s the role of doctors in boosting drug plan sustainability?

Some see it as an eternal struggle: the goodhearted doctor championing the best treatments, no matter the cost, while doing battle against the tightfisted insurance company denying claims for expensive but life-saving medications. But when you get down to it, their goals often dovetail: the best care for patients at affordable prices. After all, even […]

Drug Plan Trends Report: Alarm about costs sparks ‘monumental shift’

With drug plan costs back on the upswing amid unprecedented increases for stop-loss or pooling insurance, benefits advisors and insurers are seeing more plan sponsors voicing concerns over sustainability and showing a greater willingness to take actions beyond seeking the best rates at renewal time. “The industry is in the process of reacting to what’s […]

  • By: Karen Welds
  • March 21, 2017 September 13, 2019
  • 08:57
Sounding Board: Five ways to cut benefit costs while preserving value for staff

Last week, after years of declining revenue, Postmedia Network Inc. released an internal memo announcing significant cuts to non-unionized employees’ benefits. At first glance, the changes appear warranted for the struggling media company. Upon closer inspection, the question isn’t whether the company should have cut benefits but rather how it could have strategically reduced health-care […]

Employers face hard questions until national drug program becomes reality

I remember when employers were concerned about the potential impact of a little blue pill called Viagra that came with an annual price tag of about $1,200. In those days, $1,200 would have been a high-cost drug. In 2017, that seems like a bargain, as today’s specialty drugs cost tens of thousands of dollars per patient per year. For […]

  • March 15, 2017 September 13, 2019
  • 19:30
Switching to over-the-counter drugs could save $1B annually: report

Switching three prescription drugs classes to over-the-counter medications could save Canadians, employers, insurers and the health-care system $1 billion annually, according to a new report by the Conference Board of Canada. According to the report, the economic value of switching to over-the-counter medications is an estimated $709.9 million for proton pump inhibitors, which treat gastroesophageal […]

  • By: Staff
  • March 10, 2017 September 13, 2019
  • 09:30
Drug plan trends report: How drug plans are addressing skyrocketing costs

When Andrew Martin joined the HR department at Joey Restaurant Group eight years ago, the company hadn’t touched its paper-based, administrative services-only drug plan in many years. Martin was quick to make changes, bringing in a flexible plan, drug cards, generic substitution and copayments based on dispensing fees. Still, he stopped short of reducing the […]

  • By: Karen Welds
  • March 18, 2016 September 13, 2019
  • 09:04
Immuno-oncology shows promise but cost concerns loom

The development of new cancer treatments has created an opportunity to turn some cancers into chronic, manageable diseases and allow many people to return to work. That was one of the key messages at the 2016 Employers Cancer Care Summit as an expert panel discussed the rise and implications of the new treatments for the […]

  • By: Yaelle Gang
  • March 10, 2016 September 13, 2019
  • 14:00